Albertsons Companies, Inc. Q2 FY2025 earnings call

• Company operates with a 'new day' mindset, conducting deep dives across business facets. - Banners are trusted brands deeply embedded in communities, leveraging national scale. - E-commerce is a key growth driver, with 23% year-over-year growth and proximity to customers providing a structural advantage. - Loyalty program has 13% growth in membership, with program enhancements driving deeper engagement. - Pharmacy grew 19% due to GLP-one growth and share gains from competitor store closures. - Media collective had strong momentum in Q2 with improved ad spend return, driven by enhanced data quality and targeting. - Technology is central, with AI-powered features like Ask AI in the mobile app. - Evaluating asset base and operating model, with 29 stores closed and 9 new stores expected to open by year-end.

Adjusted identical sales grew 2.2% in the second quarter. Adjusted EBITDA was $848 million and earnings per share was $0.44. E-commerce had 23% year-over-year growth. Loyalty membership increased 13% to over 48 million. Pharmacy grew 19% year over year. The media collective showed strong momentum in the second quarter with improved year-over-year return on ad spend for partners. Revenue contribution: E-commerce, pharmacy, loyalty, and media collective each played significant roles in the company's overall financial performance.

• Increased the lower end of the identical sales range to 2.2-2.75%. - Adjusted EBITDA is expected to be in the range of $3.8 billion to $3.9 billion. - Adjusted EPS is expected to be in the range of $2.06 to $2.19. - Capital expenditures are expected to be in the range of $1.8 billion to $1.9 billion as investment in digital and automation is accelerated. - Effective income tax rate is expected to be 23.5%-24.5%, and there's a cash flow benefit of $125 million to $150 million from recent tax legislation.

Risks include factors identified in the company's filings with the SEC, such as uncertainties related to market conditions, competitive landscape, economic factors, and other elements that could cause actual results to differ materially from expectations.

Q: Edward Kelly asked about the confidence in returning to an algo in 2026 and pricing investment.

A: Susan Morris stated it's based on sticking to the five strategic priorities, with positive inflection in units from surgical price investments and productivity savings on track.

Q: Rupesh Parikh inquired about gross margin dynamics and the consumer backdrop.

A: Susan Morris noted mix shift to higher customer lifetime value areas like RX and e-commerce, and consumers focusing on value, trading down, and healthier eating.

Q: Mark Carden asked about the full year guidance and pharmacy cross-selling.

A: Sharon McCollam said the sales range increase is driven by pharmacy, and Susan Morris mentioned GLP customers have an initial impact but quick recovery.

Q: Leah Jordan questioned the comp guide cadence and productivity.

A: Susan Morris and Sharon McCollam discussed pharmacy driving comp, and productivity initiatives including offshore operations.

Q: Paul Lejuez asked about shrink and pharmacy customer breakdown.

A: Susan Morris talked about shrink improvements from tools and technology, and Sharon McCollam said pharmacy growth includes existing and new customers.

Q: Jacob Aiken Phillips asked about e-commerce and AI integration.

A: Susan Morris and Sharon McCollam discussed e-commerce's proximity advantage and AI use in various business areas.

Q: Simeon Gutman asked about ASR and e-commerce drivers.

A: Susan Morris and Sharon McCollam said ASR doesn't impact strategic initiatives, and e-commerce drivers include store proximity and app improvements.

Q: John Heinbockel asked about assets, banners, and top line volume.

A: Susan Morris discussed asset evaluation, banner flipping, and expectations for top line inflection in 2026.